The shares of Metropolis Healthcare are set to go ex-record date for its 3:1 bonus issue on Friday. Only shareholders holding the stock as of the record date will be eligible for the first-ever bonus issue announced by the diagnostic services provider.

Earlier in February, the company had announced the bonus issue while releasing its October–December quarter results for FY26. The board approved the issue of bonus shares in the ratio of 3:1, meaning three fully paid-up equity shares of face value Rs 2 each for every one fully paid-up equity share of face value Rs 2 each held by shareholders.

Later, on March 10, the company announced that the record date has been fixed as March 20 (Friday).

What does this mean for shareholders?

If a shareholder owns one share of a company worth Rs 100, a 3:1 bonus issue will convert the holding into four shares worth around Rs 25 each. The total value of the holding remains unchanged at Rs 100.Once the stock begins trading ex-bonus, the price appears to fall sharply, but this simply reflects the adjustment following the corporate action.

Only shareholders who owned the stock on the record date are eligible to receive the bonus shares. Bonus issues consist of free shares distributed by a company from its reserves and are often seen as a sign of strong financial health and growth prospects.
While the issue of bonus shares increases the total number of outstanding shares, it does not change the company’s market capitalisation. However, it can improve liquidity and affordability, allowing more investors to invest in the stock.

Metropolis Healthcare share price:

Metropolis Healthcare shares have gained around 4% in the past five days, but declined around 7% in the past one month. The small-cap stock has dropped nearly 11% in the past six months, and around 5% in 2026 so far.The stock currently has a P/E ratio of around 56, and a market capitalisation of Rs 9,382 crore, as per data on NSE.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Basmati rice exporter Amir Chand Jagdish Kumar(Exports) Ltd is set to launch its Rs 440 crore initial public offering (IPO) on March 24.

The public issue will close on March 27, while the anchor investor bidding is scheduled to take place on March 23, according to the red herring prospectus (RHP).

The Haryana-based company’s proposed IPO will comprise a fresh issue of equity shares entirely, with no offer-for-sale (OFS) component.

The company plans to utilise the net proceeds from the issue to fund its working capital requirements and for general corporate purposes.

The Securities and Exchange Board of India (Sebi) granted its approval to the IPO in October 2025.

The offer size has been reduced to Rs 440 crore compared to the Rs 550 crore issue size proposed in the Draft Red Herring Prospectus (DRHP) filed in June 2025.
Ahead of the public issue, the company raised Rs 13 crore in a pre-IPO round by allotting 7.55 lakh shares at Rs 172 per share.Amir Chand Jagdish Kumar (Exports) Ltd is a processor and exporter of basmati rice in India. The company markets its products under the flagship brand “Aeroplane”.

It competes with the likes of other large basmati rice companies, including KRBL Ltd, LT Foods and Sarveshwar Foods, and various other unorganised processors.

Apart from its core basmati rice business, the company has diversified into FMCG products, offering staples and other essential kitchen items.

For the nine-month period ended December 31, 2024, the company reported revenue from operations of Rs 1,421.3 crore and a profit after tax of Rs 48.77 crore.

The company’s shares are proposed to be listed on the BSE and NSE.